Severe Subtype of Alopecia Areata is Highly Associated with Thyroid Autoimmunity

Overview

Journal Saudi Med J

Specialty General Medicine

Date 2016 Jun 10

PMID 27279512

Citations 10

Authors

Ghada A Bin Saif

Affiliations

Soon will be listed here.

Abstract

Objectives: To assess the significance of thyroid autoimmune screening in alopecia areata (AA) patients in Saudi population, and to determine whether there is a difference in thyroid autoimmune susceptibility between mild and severe AA.

Methods: In a prospective case-control study, we included 50 alopecia totalis (AT) and alopecia universalis (AU) patients, 50 age- and gender-matched patients with localized AA, and 50 age- and gender- matched healthy subjects between March 2015 and August 2015. Patients with AA were consecutively recruited from the hair disorders out-patient clinic of King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia.

Results: Thyroid autoantibodies (TAAs) were positive in AT/AU (40%), mild AA (14%), and healthy subjects (4%). The frequency of TAAs was significantly higher in patients with AT/AU than in mild AA (p=0.001) and healthy controls (p less than 0.001). The frequency of thyroid peroxidase antibody (TPO-Abs) was significantly higher in patients with AT/AU than in mild AA and healthy controls (p less than 0.001 for both). The frequency of TG-Abs was significantly higher in patients with AT/AU (p=0.003) and mild AA (p=0.043) than in healthy controls. Serum TSH level was significantly higher in AT/AU patients than in mild AA patients (p=0.006) and healthy controls (p=0.005).

Conclusion: Severe subtype of AA is associated with a high risk of autoimmune thyroid disease. This highlights the significance of screening for thyroid abnormalities and TAAs in patients with AT/AU.

Citing Articles

Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopecia Areata: A Cross-Sectional Study.

Stefanis A, Fialova A, Arenberger P Skin Appendage Disord. 2025; 11(1):1-8.

PMID: 39911978 PMC: 11793901. DOI: 10.1159/000540220.

Thyroid Dysfunction and Alopecia Areata: A Genetic Prediction Causality Analysis Study.

Zhao Y, Guo F, Guo M Skin Res Technol. 2024; 30(10):e70063.

PMID: 39331482 PMC: 11430218. DOI: 10.1111/srt.70063.

The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study.

Gao L, Li W, Song Q, Gao H, Chen M Front Endocrinol (Lausanne). 2024; 15:1440941.

PMID: 39205687 PMC: 11349512. DOI: 10.3389/fendo.2024.1440941.

An Update on Alopecia and its Association With Thyroid Autoimmune Diseases.

Aboalola D, Aouabdi S, Ramadan M, Alghamdi T, Alsolami M, Malibari D touchREV Endocrinol. 2024; 19(2):54-59.

PMID: 38187080 PMC: 10769472. DOI: 10.17925/EE.2023.19.2.10.

Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis.

Ly S, Manjaly P, Kamal K, Shields A, Wafae B, Afzal N Am J Clin Dermatol. 2023; 24(6):875-893.

PMID: 37464249 DOI: 10.1007/s40257-023-00805-4.

References

Green J, Sinclair R . Genetics of alopecia areata. Australas J Dermatol. 2000; 41(4):213-8. DOI: 10.1046/j.1440-0960.2000.00439.x. View

Lee S, Paik S, Kim H, Ryu H, Cha S, Jo S . Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis. PLoS One. 2013; 8(1):e53613. PMC: 3543254. DOI: 10.1371/journal.pone.0053613. View

Unuane D, Velkeniers B, Anckaert E, Schiettecatte J, Tournaye H, Haentjens P . Thyroglobulin autoantibodies: is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment?. Thyroid. 2013; 23(8):1022-8. PMC: 3752510. DOI: 10.1089/thy.2012.0562. View

Strieder T, Prummel M, Tijssen J, Endert E, Wiersinga W . Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003; 59(3):396-401. DOI: 10.1046/j.1365-2265.2003.01862.x. View

Chu S, Chen Y, Tseng W, Lin M, Chen T, Hwang C . Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011; 65(5):949-56. DOI: 10.1016/j.jaad.2010.08.032. View

Sharma V, Dawn G, Kumar B . Profile of alopecia areata in Northern India. Int J Dermatol. 1996; 35(1):22-7. DOI: 10.1111/j.1365-4362.1996.tb01610.x. View

Padberg S, Heller K, Usadel K, Schumm-Draeger P . One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit?. Thyroid. 2001; 11(3):249-55. DOI: 10.1089/105072501750159651. View

Redler S, Albert F, Brockschmidt F, Herold C, Hanneken S, Eigelshoven S . Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata. Br J Dermatol. 2012; 167(6):1360-5. DOI: 10.1111/bjd.12004. View

Alkhalifah A, Alsantali A, Wang E, McElwee K, Shapiro J . Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010; 62(2):177-88, quiz 189-90. DOI: 10.1016/j.jaad.2009.10.032. View

10.

Seyrafi H, Akhiani M, Abbasi H, Mirpour S, Gholamrezanezhad A . Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol. 2005; 5:11. PMC: 1280924. DOI: 10.1186/1471-5945-5-11. View

11.

Barahmani N, Schabath M, Duvic M . History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009; 61(4):581-91. DOI: 10.1016/j.jaad.2009.04.031. View

12.

Cunliffe W, Hall R, Stevenson C, Weightman D . Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol. 1969; 81(12):877-81. DOI: 10.1111/j.1365-2133.1969.tb15967.x. View

13.

Fan Y, Xu S, Zhang H, Cao W, Wang K, Chen G . Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol. 2015; 2014:904573. PMC: 4276677. DOI: 10.1155/2014/904573. View

14.

Bakry O, Basha M, El Shafiee M, Shehata W . Thyroid disorders associated with alopecia areata in egyptian patients. Indian J Dermatol. 2014; 59(1):49-55. PMC: 3884928. DOI: 10.4103/0019-5154.123494. View

15.

Hollowell J, Staehling N, Flanders W, Hannon W, Gunter E, Spencer C . Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87(2):489-99. DOI: 10.1210/jcem.87.2.8182. View

16.

Goh C, Finkel M, Christos P, Sinha A . Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol. 2006; 20(9):1055-60. DOI: 10.1111/j.1468-3083.2006.01676.x. View

17.

Bertolini M, Gilhar A, Paus R . Alopecia areata as a model for T cell-dependent autoimmune diseases. Exp Dermatol. 2012; 21(6):477-9. DOI: 10.1111/j.1600-0625.2011.01427.x. View

18.

Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A . Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol. 1994; 33(9):632-3. DOI: 10.1111/j.1365-4362.1994.tb02921.x. View

19.

AlFadhli S, Nanda A . Genetic analysis of interleukin-1 receptor antagonist and interleukin-1β single-nucleotide polymorphisms C-511T and C+3953T in alopecia areata: susceptibility and severity association. Clin Exp Med. 2013; 14(2):197-202. DOI: 10.1007/s10238-013-0228-7. View

20.

Al-Khawajah M . Alopecia areata and associated diseases in Saudi patients. Ann Saudi Med. 1991; 11(6):651-4. DOI: 10.5144/0256-4947.1991.651. View